3 years ago

BioCertica Secures $1.6M Seed Funding to Expand Direct-to-Consumer Genetics Platform

  • South African biotechnology startup BioCertica has raised $1.6 million in seed funding from the Ministry of Programming

  • BioCertica is a direct-to-consumer genetics company that uses polygenic risk score (PRS) to give DNA test results

  • The company's platform provides users with tailored genetic results and offers a variety of lifestyle-based DNA test kits for a variety of purposes, including nutrition and well-being, ancestry, fitness, weight management, cardiovascular health, skincare, and mental health

  • The funding will be used to further develop the company's platform and expand its reach in the South African market.

      • ProblemHealthcare

      "Traditional genetic testing methods often lack resolution and accuracy in diagnosing genetic predispositions to health conditions, hindering preventative care and personalized health insights."

      Solution

      "BioCertica offers a direct-to-consumer genetic testing platform using polygenic risk score (PRS) technology. This provides higher-resolution DNA test results, improving the accuracy of diagnosing genetic susceptibility to various health conditions and offering personalized health recommendations."

      Covered on